You just read:

Alder BioPharmaceuticals Inc. Closes $38 Million Series D Financing to Accelerate Clinical Development of its Pipeline of Antibody Therapeutics

News provided by

Alder Biopharmaceuticals Inc.

Apr 19, 2012, 07:30 ET